NCT05764226View on ClinicalTrials.gov

Freshly Manufactured 35kDa Hyaluronan Fragment HA35 for the Treatment of Chronic Wounds

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 6, 2020

Primary Completion Date

December 29, 2022

Study Completion Date

February 8, 2023

Conditions
Chronic Wounds
Interventions
DRUG

HA35(L20200708MP07707, Ministry of Health, Mongolia)was freshly manufactured by mixing hyaluronidase PH20 injectable solution (H31022111) and high-molecular-weight HA injectable solution (H20174089)

One hundred milligrams of the freshly made 35 kDa low molecular weight HA fragment HA35 was injected into the tissue under the heath skin immediately surrounding the chronic wounds once a day for 10 days.

Trial Locations (1)

150000

Far East Hospital, Harbin

All Listed Sponsors
collaborator

Mongolian National University of Medical Sciences

OTHER

lead

Nakhia Impex LLC

INDUSTRY

NCT05764226 - Freshly Manufactured 35kDa Hyaluronan Fragment HA35 for the Treatment of Chronic Wounds | Biotech Hunter | Biotech Hunter